A Review on Isoniazid and Rifampicin-Associated Hepatotoxicity: From Metabolism to Immunity
{{output}}
Isoniazid (INH) and rifampicin (RIF) are cornerstone first-line antituberculosis drugs, yet their clinical utility is often limited by drug-induced liver injury (DILI). Understanding the mechanistic basis of INH and RIF-induced hepatotoxicity is essential for ... ...
